Drug
Prostaglandin E1
Prostaglandin E1 is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
2(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (100.0%)
Trials by Status
completed133%
unknown267%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_4
Intravenous Dexamethasone for Inducing Labor in Women With Term Pregnancy and Pre-Labour Rupture of Membranes
NCT07503184
unknown
Effects of Prostaglandin E1 Treatment on Pyloric Wall in Newborns
NCT04496050
unknownphase_4
The Use of Prostaglandin E1 in Head and Neck Microsurgery
NCT00733434
Clinical Trials (3)
Showing 3 of 3 trials
NCT07503184Phase 4
Intravenous Dexamethasone for Inducing Labor in Women With Term Pregnancy and Pre-Labour Rupture of Membranes
NCT04496050
Effects of Prostaglandin E1 Treatment on Pyloric Wall in Newborns
NCT00733434Phase 4
The Use of Prostaglandin E1 in Head and Neck Microsurgery
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3